Compositions and methods for detecting an rna virus
AssigneeEnvirologix Inc.
InventorsLars PETERS, Stephen A. JUDICE, Daniel SHAFFER, Breck PARKER
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for rapidly identifying an RNA viral infection using an isothermal nucleic acid amplification reaction that can be carried out on extracted RNA in the context of a crude biological sample.
Claims79
A method of detecting a specific target polynucleotide in an isothermal amplification reaction coupled with reverse transcription, the method comprising:
- (a) contacting a target polynucleotide molecule in a sample with a primer in the presence of a reverse transcriptase and dNTPs under conditions permissive for cDNA synthesis, thereby generating a cDNA;
- (b) contacting the cDNA with forward and reverse primers each carrying at least one nicking enzyme recognition sequence within their respective 5′-terminal regions which specifically bind the cDNA with their respective 3′-terminal regions in the presence of a nicking enzyme, dNTPs, a detectable oligonucleotide probe, and a strand-displacement polymerase under conditions permissive for the isothermal amplification of the cDNA;
- and
- (c) detecting a signal specific for detectable oligonucleotide probe hybridization to the amplicon, wherein detection of the signal indicates the presence or quantity of the target polynucleotide present in the sample and failure to detect the signal indicates the absence of target polyribonucleotide in the sample.
A method of detecting an RNA virus in a sample, the method comprising
- (a) contacting an RNA virus polynucleotide molecule in a sample with a primer in the presence of a reverse transcriptase and dNTPs under conditions permissive for cDNA synthesis, thereby generating a cDNA;
- (b) contacting the cDNA with forward and reverse primers each carrying at least one nicking enzyme recognition sequence within their respective 5′-terminal regions which specifically bind the cDNA with their respective 3′-terminal regions in the presence of a nicking enzyme, dNTPs, a detectable oligonucleotide probe, and a strand-displacement polymerase under conditions permissive for the isothermal amplification of the cDNA;
- and
- (c) detecting a signal specific for detectable oligonucleotide probe hybridization to the amplicon, wherein detection of the signal indicates the presence or quantity of the RNA virus polynucleotide molecule present in the sample and failure to detect the amplicon indicates the absence of an RNA virus.
A method of detecting an Ebola virus in a sample, the method comprising
- (a) contacting a Ebola polynucleotide in a sample with a primer in the presence of a reverse transcriptase and dNTPs under conditions permissive for cDNA synthesis, thereby generating a cDNA;
- (b) contacting the cDNA with forward and reverse primers each carrying at least one nicking enzyme recognition sequence within their respective 5′-terminal regions which specifically bind the cDNA with their respective 3′-terminal regions in the presence of a nicking enzyme, dNTPs, a detectable oligonucleotide probe, and a strand-displacement polymerase under conditions permissive for the isothermal amplification of the cDNA;
- and
- (c) detecting a signal specific for detectable oligonucleotide probe hybridization to the amplicon, wherein detection of the signal indicates the presence or quantity of the Ebola polynucleotide present in the sample and failure to detect the signal indicates the absence of Ebola polynucleotide present in the sample.
A method of detecting an Ebola virus in a sample, the method comprising
- (a) contacting a biological sample with an agent capable of extracting an polynucleotide molecule present in the sample and an agent capable of stabilizing an polynucleotide molecule against degradation;
- (b) contacting the extracted and stabilized Ebola RNA with a primer in the presence of a reverse transcriptase and dNTPs under conditions permissive for cDNA synthesis, thereby generating an Ebola cDNA;
- (c) contacting the Ebola cDNA with forward and reverse primers each carrying at least one nicking enzyme recognition sequence within their respective 5′-terminal regions which specifically bind the Ebola cDNA with their respective 3′-terminal regions in the presence of a nicking enzyme, dNTPs, and a strand-displacement polymerase under conditions permissive for the isothermal amplification of the cDNA, thereby generating amplicons;
- and
- (d) detecting the amplicons, wherein the presence of an Ebola amplicon detects an Ebola polynucleotide molecule in the sample and failure to detect the amplicon indicates the absence of an Ebola polynucleotide in the sample.
A kit for detecting an RNA virus polynucleotide molecule comprising primers that specifically bind an RNA viral sequence, a detectable probe that specifically binds an RNA virus amplicon, a reverse transcriptase enzyme, a nicking enzyme, and a strand-displacement polymerase.
A kit for amplifying an Ebola polynucleotide molecule in a reverse transcriptase nicking amplification reaction, the kit comprising the following primers:
- Forward primer:
- GACTCGATATCGAGTCGCTTCCA[MeOC]AGTTATC[MeOU]
- [MeOA][MeOC][MeOC][MeOG]
- Reverse Primer:
- GACTCGATATCGAGTCGAAATGC[MeOA]ACGA[MeOC]
- [MeOA][MeOC][MeOC][MeOU];
- the following probe:
- gctacACGACTTTYGCTGAAGgtagc;
- a reverse transcriptase enzyme, a nicking enzyme, a strand-displacement polymerase, and directions for use of the aforementioned primers, probes and enzymes for detecting an Ebola polynucleotide molecule.
A kit for amplifying an HIV polynucleotide molecule in a reverse transcriptase nicking amplification reaction, the kit comprising one or more of the following primers:
- GACTCGATATCGAGTCTGACTAGmCGGAGGmCmTmAmGmAmAmG,
- GACTCGATATCGAGTCTGACTAGmCAGAGGmCmTmAmGmAmAmG;
- and
- Reverse Primer:
- GACTCGATATCGAGTCTATTGACmGCTCmTmCmGmCmAmC,
- GACTCGATATCGAGTCTACTGACmGCTCmTmCmGmCmAmC;
- the following probe:
- cgcaagGGAGAGAGATGGGTGcttgcg;
- a reverse transcriptase enzyme, a smoking enzyme, a strand-displacement polymerase, and directions for use of the aforementioned primers, probes and enzymes for detecting an HIV polynucleotide molecule.
A kit for amplifying a Dengue polynucleotide molecule in a reverse transcriptase nicking amplification reaction, the kit comprising one or more of the following primers:
- Forward primer:
- GACTCGATATCGAGTCCAAAAACmAGCATATTmGmAmCmGmC;
- and
- Reverse Primer:
- GACTCGATATCGAGTCAGACAGCmAGGATCmTmCmTmGmG,
- GACTCGATATCGAGTCAGACAGCmAGGATCmTmGmTmGmG;
- the following probe:
- cgcatcTGGTCTTTCCCAGCgatgcg;
- a reverse transcriptase enzyme, a nicking enzyme, a strand-displacement polymerase, and directions for use of the aforementioned primers, probes and enzymes for detecting an Dengue polynucleotide molecule.
A kit for amplifying an influenza B polynucleotide molecule in a reverse transcriptase nicking amplification reaction, the kit comprising one or more of the following primers:
- Forward primer:
- GACTCGATATCGAGTCAAATGCAmGATGGTCTCmAmGmCmTmA,
- GACTCGATATCGAGTCAAATGCAmAATGGTCTCmAmGmCmTmA,
- GACTCGATATCGAGTCAAATGCAmGATGGTTTCmAmGmCmTmA;
- and
- Reverse Primer:
- GACTCGATATCGAGTCCTCCTTTmTCCCATTCCATmTmCmAmTmT,
- GACTCGATATCGAGTCCTCCCTTmTCCCATTCCATmTmCmAmTmT,
- GACTCGATATCGAGTCCTCCTTTmCCCCATTCCATmTmCmAmTmT;
- the following probe:
- gccaaGCTATGAACACAGCAAActtggc;
- a reverse transcriptase enzyme, a nicking enzyme, a strand-displacement polymerase, and directions for use of the aforementioned primers, probes and enzymes for detecting an influenza B polynucleotide molecule.
A kit for amplifying a BVDV1 polynucleotide molecule in a reverse transcriptase nicking amplification reaction, the kit comprising one or more of the following primers:
- GACTCGATATCGAGTCGGCCCACmTGTATTGCTmAmCmTmGmAmAmA,
- GACTCGATATCGAGTCGGCCCACmTGCACTGCTmAmCmTmAmAmAmA;
- and
- Reverse Primer:
- GACTCGATATCGAGTCTGTGATCmAACTCCmAmTmGmTmGmCmC;
- the following probe:
- gctacACGACTTTYGCTGAAGgtagc;
- a reverse transcriptase enzyme, a nicking enzyme, a strand-displacement polymerase, and directions for use of the aforementioned primers, probes and enzymes for detecting an BVDV1 polynucleotide molecule.
A method of diagnosing a human or animal subject with an RNA virus, the method comprising
- (a) contacting a sample of the subject with an agent capable of extracting an RNA virus present in the sample and an agent capable of stabilizing the extracted polynucleotide molecule against degradation;
- (b) contacting the polynucleotide molecule with a reverse transcriptase primer in the presence of a reverse transcriptase and dNTPs under conditions permissive for cDNA synthesis, thereby generating a cDNA copy of the polynucleotide molecule;
- (c) contacting the cDNA with forward and reverse primers carrying at least one nicking enzyme recognition sequence within their respective 5′-terminal regions which specifically bind the cDNA with their respective 3′-terminal regions in the presence of a nicking enzyme, dNTPs, and a strand-displacement polymerase under conditions permissive for the isothermal amplification of the cDNA, thereby generating amplicons;
- and
- (d) detecting the amplicons, wherein the presence of an RNA viral amplicon diagnoses an RNA viral infection in the subject and failure to detect the amplicon diagnoses the absence of an RNA viral infection in the subject.
Dependencies are inferred from the claim text.